SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-17-002994
Filing Date
2017-04-27
Accepted
2017-04-27 16:39:05
Documents
4
Period of Report
2017-06-13
Effectiveness Date
2017-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2231974zdef14a.htm DEF 14A 397404
2 G316236.JPG g316236.jpg GRAPHIC 6552
3 G22192BGI001.GIF g22192bgi001.gif GRAPHIC 148441
4 G22192BGI002.GIF g22192bgi002.gif GRAPHIC 104519
  Complete submission text file 0001047469-17-002994.txt   756095
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: DEF 14A | Act: 34 | File No.: 001-35518 | Film No.: 17789690
SIC: 2834 Pharmaceutical Preparations